(Walter + Eliza Hall Institute [Australia]) June 26, 2017 - An international research team has found a way to improve the anti-cancer effect of a new medicine class called ‘Smac mimetics’.

(Yahoo! Finance) June 26, 2017 - ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, presented data from the ongoing Phase 1 study evaluating single agent IMGN779 in patients with relapsed or refractory adult acute myeloid leukemia (AML) whose tumors express CD33.